Logo

American Heart Association

  16
  0


Final ID: Su3083

Impact of adherence to the global algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention

Abstract Body (Do not enter title and authors here): Background: The effect of selecting the initial crossing strategy using the global chronic total occlusion (CTO) crossing algorithm on the outcomes of CTO percutaneous coronary intervention (PCI) has not been studied.
Methods: We examined the clinical and angiographic characteristics and procedural outcomes of 13,852 CTO PCIs at 43 US and non-US centers between 2012 and 2025. Adherence to the global CTO crossing algorithm was defined using three key case characteristics - proximal cap ambiguity, poor distal vessel quality, and use of antegrade dissection/re-entry (ADR) as the primary strategy (Figure 1).
Results: Among 13,852 CTO PCIs, 70% (n=9,693) adhered to the global CTO crossing algorithm. Adherence remained consistent over time. Patients in the discordant group (non-adherent) were younger and more likely to have a history of myocardial infarction (MI) rates, while the concordant group (adherent) had more unstable angina presentations and ad hoc procedures. Discordant cases more frequently targeted the right coronary artery (61.5% vs 49.4%, p<0.001) and exhibited greater complexity: longer occlusions, proximal cap ambiguity, blunt/no stump, poor distal vessel quality, and calcification (all p<0.001). Discordant lesions also had higher J-CTO (2.8±1.2 vs 2.1±1.1; p=0.001) and PROGRESS-CTO complication scores. The retrograde approach was utilized more often as the primary crossing strategy in concordant cases (15.3% vs 4.4%; p<0.001) but was less often the successful crossing strategy (14.9% vs 28.1%; p<0.001). Discordant procedures required more stents, longer duration, higher contrast volume, fluoroscopy time, and radiation dose (all p<0.001). Algorithm adherence was associated with higher crossing success with the initially selected technique (72.5% vs 49.4%), technical (87.9% vs 85.6%), and procedural success (86.7% vs 84.2%) (all p<0.001). The incidence of perforation was lower in concordant cases (4.1% vs 6.1%; p<0.001), although major adverse cardiovascular events (MACE) were comparable. On multivariable analysis algorithm adherence was independently associated with technical success (odds ratio 1.24; 95% confidence interval 1.06 – 1.44; p=0.007).
Conclusions: Adhering to the global CTO crossing algorithm for initial crossing strategy selection is associated with higher likelihood of success with the initial strategy, better technical success rates, and similar in-hospital MACE.
  • Rempakos, Athanasios  ( Corewell Health , Troy , Michigan , United States )
  • Alaswad, Khaldoon  ( Henry Ford Hospital , Detroit , Michigan , United States )
  • Basir, Babar  ( HENRY FORD HOSPITAL , Detroit , Michigan , United States )
  • Khelimskii, Dmitrii  ( MESHALKIN NATIONAL RESEARCH CENTER , Novosibirsk , Russian Federation )
  • Jaffer, Farouc  ( MASSACHUSETTS GENERAL HOSPITAL , Boston , Massachusetts , United States )
  • Abi Rafeh, Nidal  ( STATEN ISLAND UNIVERSITY HOSP , Staten Island , New York , United States )
  • Chandwaney, Raj  ( OKLAHOMA HEART INSTITUTE , Tulsa , Oklahoma , United States )
  • Cevik, Cihan  ( UC Health Memorial Hospital , Colorado Springs , Colorado , United States )
  • Ahmad, Yousif  ( UCSF , San Francisco , California , United States )
  • Mastrodemos, Olga  ( MHIF , Minneapolis , Minnesota , United States )
  • Rangan, Bavana  ( Minneapolis Heart Institute Foundn , Minneapolis , Minnesota , United States )
  • Mutlu, Deniz  ( Minneapolis Heart Institute Foundat , Minneapolis , Minnesota , United States )
  • Jalli, Sandeep  ( Minneapolis Heart Institute , Minneapolis , Minnesota , United States )
  • Voudris, Konstantinos  ( Allina Minneapolis Heart Institute , Minneapolis , Minnesota , United States )
  • Sandoval, Yader  ( Minneapolis Heart Institute , Minneapolis , Minnesota , United States )
  • Burke, M Nicholas  ( Minneapolis Heart Institute , Mpls , Minnesota , United States )
  • Brilakis, Emmanouil  ( Minneapolis Heart Institute , Edina , Minnesota , United States )
  • Alexandrou, Michaella  ( Minneapolis Heart Institute Foundat , Minneapolis , Minnesota , United States )
  • Strepkos, Dimitrios  ( Minneapolis Heart Institute , Minneapolis , Minnesota , United States )
  • Carvalho, Pedro  ( Minneapolis Heart Institute Foundat , Minneapolis , Minnesota , United States )
  • Kladou, Eleni  ( Minneapolis Heart Institute , Minneapolis , Minnesota , United States )
  • Ybarra, Luiz  ( London Health Sciences Center , London , Ontario , Canada )
  • Sara, Jaskanwal Deep  ( Minneapolis Heart Institute , Minneapolis , Minnesota , United States )
  • Ser, Ozgur  ( Minneapolis Heart Institute Foundat , Minneapolis , Minnesota , United States )
  • Author Disclosures:
    Athanasios Rempakos: DO NOT have relevant financial relationships | Khaldoon Alaswad: DO NOT have relevant financial relationships | Babar Basir: DO have relevant financial relationships ; Consultant:Abiomed:Active (exists now) ; Consultant:Zoll:Active (exists now) ; Consultant:Chiesi:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) | Dmitrii Khelimskii: DO NOT have relevant financial relationships | Farouc Jaffer: No Answer | Nidal Abi Rafeh: No Answer | Raj Chandwaney: DO NOT have relevant financial relationships | CIHAN CEVIK: DO NOT have relevant financial relationships | Yousif Ahmad: No Answer | Olga Mastrodemos: DO NOT have relevant financial relationships | Bavana Rangan: No Answer | Deniz Mutlu: DO NOT have relevant financial relationships | Sandeep Jalli: No Answer | Konstantinos Voudris: No Answer | Yader Sandoval: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Consultant:Roche :Active (exists now) ; Consultant:Philips:Active (exists now) ; Speaker:Medtronic:Active (exists now) ; Speaker:Heartflow:Active (exists now) ; Consultant:Heartflow:Active (exists now) ; Consultant:GE Healthcare:Active (exists now) ; Speaker:Cleerly:Active (exists now) ; Research Funding (PI or named investigator):Cleerly:Active (exists now) ; Speaker:Cleerly:Active (exists now) ; Consultant:Cathworks :Active (exists now) | M Nicholas Burke: DO have relevant financial relationships ; Ownership Interest:Egg Medical:Active (exists now) | Emmanouil Brilakis: DO have relevant financial relationships ; Consultant:Abbott Vascular:Active (exists now) ; Individual Stocks/Stock Options:Cleerly Health:Active (exists now) ; Ownership Interest:Hippocrates LLC:Active (exists now) ; Consultant:Orbus Neich:Past (completed) ; Consultant:Teleflex:Active (exists now) ; Consultant:SIS Medical:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:IMDS:Active (exists now) ; Consultant:Haemonetics:Active (exists now) ; Consultant:GE Healthcare:Active (exists now) ; Royalties/Patent Beneficiary:Elsevier:Active (exists now) ; Consultant:CSI:Past (completed) ; Consultant:Cordis:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Biotronik:Active (exists now) | Michaella Alexandrou: DO NOT have relevant financial relationships | Dimitrios Strepkos: DO NOT have relevant financial relationships | Pedro Carvalho: DO NOT have relevant financial relationships | Eleni Kladou: DO NOT have relevant financial relationships | Luiz Ybarra: DO have relevant financial relationships ; Advisor:Abbott Cardiovascular:Past (completed) | Jaskanwal Deep Sara: DO NOT have relevant financial relationships | Ozgur Ser: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Tools & Techniques for Complex PCI and CTO Revascularization

Sunday, 11/09/2025 , 11:30AM - 12:30PM

Abstract Poster Board Session

More abstracts on this topic:
Adherence to Antihypertensive Medication Varies by Insurance Status in US Adults: The Behavior Risk Factor Surveillance System (BRFSS) Study (2019-2023)

Jurado Velez Javier, Hidalgo Bertha

A Multifaceted Blood Pressure Intervention Improves Medication Adherence in Low Income Adults with Hypertension

Krousel-wood Marie, Mitchell Tammy, Gray Winfrey Lea, Williams Shondra, Wiltz Gary, Winfrey Keith, Chen Jing, He Jiang, Peacock Erin, Mills Katherine, Allouch Farah, Cyprian Alecia, Davis Gerrelda, Fuqua Sonja, S Gilliam Darie, Greer Angel

More abstracts from these authors:
Outcomes of Coronary Chronic Total Occlusion Modification procedures

Kladou Eleni, Krestyaninov Oleg, Khatri Jaikirshan, Young Laura, Goktekin Omer, Poommipanit Paul, Jaffer Farouc, Gorgulu Sevket, Arun Diya, Kalyanasundaram Arun, Mastrodemos Olga, Strepkos Dimitrios, Rangan Bavana, Jalli Sandeep, Voudris Konstantinos, Sandoval Yader, Burke M Nicholas, Brilakis Emmanouil, Alexandrou Michaella, Mutlu Deniz, Carvalho Pedro, Ser Ozgur, Alaswad Khaldoon, Basir Babar, Khelimskii Dmitrii

Cardio-Kidney-Metabolic Syndrome in Chronic Total Occlusion Percutaneous Coronary Intervention

Kumar Sant, Khelimskii Dmitrii, Jaffer Farouc, Abi Rafeh Nidal, Chandwaney Raj, Cevik Cihan, Ahmad Yousif, Mastrodemos Olga, Rangan Bavana, Jalli Sandeep, Voudris Konstantinos, Strepkos Dimitrios, Sandoval Yader, Burke M Nicholas, Brilakis Emmanouil, Alexandrou Michaella, Mutlu Deniz, Carvalho Pedro, Sara Jaskanwal Deep, Ser Ozgur, Alaswad Khaldoon, Basir Babar

You have to be authorized to contact abstract author. Please, Login
Not Available